{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:49:22Z","timestamp":1763534962135,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jpurol.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T07:48:41Z","timestamp":1215071321000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity"],"prefix":"10.1016","volume":"4","author":[{"given":"Pramod P.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels G.","family":"Borgstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rien J.M.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela I.","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s004310100741","article-title":"Bladder-sphincter dysfunction in myelomeningocele","volume":"160","author":"van Gool","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpurol.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00042307-200211000-00005","article-title":"Conservative management in neurogenic bladder dysfunction","volume":"12","author":"Aslan","year":"2002","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00042307-199907000-00005","article-title":"Neurogenic bladder dysfunction","volume":"9","author":"Madersbacher","year":"1999","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-5347(01)62703-4","article-title":"Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.ju.0000147813.28822.d2","article-title":"Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction","volume":"173","author":"Franco","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0090-4295(97)00489-5","article-title":"Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia","volume":"51","author":"Goessl","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-5347(01)65238-8","article-title":"Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population","volume":"157","author":"Palmer","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-5347(01)65806-3","article-title":"Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder","volume":"156","author":"Kaplinsky","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine-a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpurol.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1464-410X.2005.05641.x","article-title":"Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children","volume":"96","author":"Ayan","year":"2005","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.jpurol.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1464-410X.2003.04085.x","article-title":"The use of tolterodine in children after oxybutynin failure","volume":"91","author":"Bolduc","year":"2003","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.jpurol.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(99)00477-X","article-title":"Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia","volume":"55","author":"Goessl","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-5347(05)66576-7","article-title":"Use of tolterodine in children with dysfunctional voiding: an initial report","volume":"165","author":"Munding","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000152322.17542.63","article-title":"Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials","volume":"173","author":"Nijman","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.ju.0000176622.81796.89","article-title":"Use of tolterodine in children with neurogenic detrusor overactivity: relationship between dose and urodynamic response","volume":"174","author":"Ellsworth","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000019701","article-title":"Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children","volume":"34","author":"Amark","year":"1998","journal-title":"Eur Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513108003173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513108003173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:34:31Z","timestamp":1761485671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513108003173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1477513108003173"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2008.05.003","relation":{},"ISSN":["1477-5131"],"issn-type":[{"type":"print","value":"1477-5131"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}